The longer psychosis goes untreated, the more daily burdens pile up1-3

Impairments in activities of daily living (ADL) function are common hallmarks of schizophrenia.3 These impairments can rapidly accumulate with each psychotic episode and prevent patients from achieving or maintaining functional independence.1,3,4

SEE HOW RELAPSE CAN AFFECT DAILY LIVING

32%

The majority of patients have difficulty completing everyday tasks3

In a 2018 study of 100 patients living with schizophrenia (mean duration of illness was 9 years), investigators utilized the Lawton Instrumental Activities of Daily Living (LIADL) scale to measure patients’ proficiency across various ADLs. Overall, nearly all patients demonstrated marked deficiencies across multiple domains.3

Overall, only 2% of the patients surveyed were completely independent in their instrumental activities of daily living.3

DISCOVER HOW CSC CAN IMPROVE OUTCOMES

Functional Outcomes With CSC6

Months Since Admission Symptoms Occupational Functioning Social Functioning 0 3 6 9 12

Coordinated specialty care (CSC) helps patients reclaim daily and global functioning

Since 2013, the RAISE program has facilitated a rapid expansion in multicomponent early-psychosis intervention programs.5,6 Studies suggest that these programs confer wide-reaching benefits to patients, including enhanced treatment engagement, symptomatic and functional improvement, medication adherence, and fewer hospitalizations, all of which contribute to improved daily functioning.6-9 By keeping symptoms in remission through resiliency training and reducing the frequency of relapse and related hospitalizations, CSC empowers patients to reclaim their personal and professional aspirations.6-9

Comprehensive, early-phase psychosis intervention programs give patients the best chance to recover in key functional domains.6

Teva is committed to providing education and enhancing care for everyone living with schizophrenia.

The SCZ Now initiative was created to help support this educational effort.